Transaction #26516 · Form 4 · 0000905148-26-000003
Zai Lab Ltd · Exercise / conversion · American Depositary Shares
Zai Lab Ltd · Transacted December 30, 2025 · Filed January 2, 2026
What does this filing report?
An SEC Form 4 filing for Zai Lab Ltd records an exercise / conversion involving American Depositary Shares on December 30, 2025. The reported quantity was 21,000. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Zai Lab Ltd
- Company CIK
- 0001704292
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 21,000
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 63,178
- Ownership description
- Not reported
- SEC acceptance time
- Jan 2, 2026, 4:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Amado Rafael ↗
See Remarks
CIK 0001662119
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- F2
- ADSs acquired upon vesting of Restricted Share Units ("RSUs").
- F3
- Each RSU represents a contingent right to receive one ADS.
- F4
- These ADSs were sold automatically to cover taxes upon vesting of RSUs.
- F5
- These RSUs vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.
Remarks
President, Head of Global Oncology Research and Development
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.